Delivery Order SPE2DB22D1017-SPE2DB24FF8LZ
Award Date
5/29/24
Potential Completion Date
6/20/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the supply of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract is a firm fixed-price contract with an ultimate completion date of April 4, 2025. There is no set-aside designation, indicating this was an open competition. AmerisourceBergen holds a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for ESBRIET 267 MG CAPSULE 270S, with a potential value of $3,311.50 and a completion date of March 28, 2024. Amerisourcebergen Drug Corp, as the prime contractor, provides a wide range of pharmaceutical products and medical supplies to U.S....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $3,311.50 firm fixed-price contract is for the supply of 4565962929 ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024 and was awarded on September 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,311.50 Firm Fixed Price Delivery Order is for the supply of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has an ultimate completion date of September 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 delivery order contract is for the supply of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has a ceiling value of $3,425.95 and runs through March 20, 2025. The contract is a firm fixed-price delivery order and does not have any set-aside requirements. AmerisourceBergen Drug Corp...
This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ESBRIET 267 MG CAPSULE 270S. The contract has a ceiling value of $9,934.50 and a period of performance through October 15, 2024. This contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ESBRIET 267 MG CAPSULE 270S. The contract has a ceiling value of $3,311.50 and a completion date of May 28, 2024. It is a firm fixed price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,311.50 firm fixed-price delivery order is for the supply of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has an ultimate completion date of March 29, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order worth $3,311.50 by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product, with a completion date of March 26, 2024. This delivery order is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through...